Nutrition & DietPress Release

McGill Scientists Find Molecular Switch in Brown Fat That Burns Calories and Builds Bone

A newly identified trigger in brown fat activates a hidden calorie-burning pathway and may unlock new treatments for bone disease.

Wednesday, May 13, 2026 0 views
Published in ScienceDaily Nutrition
Article visualization: McGill Scientists Find Molecular Switch in Brown Fat That Burns Calories and Builds Bone

Summary

Scientists at McGill University have discovered a molecular switch that activates a hidden energy-burning system in brown fat. When the body gets cold, fat breakdown releases a molecule called glycerol, which binds to an enzyme called TNAP, triggering an alternative heat-producing pathway called the futile creatine cycle. This is the first time researchers have identified what activates this secondary system. Crucially, TNAP also plays a central role in bone formation, meaning this discovery could lead to new treatments for hypophosphatasia, a rare disorder causing soft, fracture-prone bones. The findings, published in Nature, open new avenues in both metabolic and bone health research.

Deep Dive Audio
0:00--:--

Detailed Summary

Researchers at McGill University have identified a previously unknown molecular trigger inside brown fat, the calorie-burning fat tissue that generates body heat. The discovery, published in Nature, sheds new light on how the body regulates energy and could eventually transform treatment for bone disease.

Unlike white fat, which stores energy, brown fat burns calories to produce heat. Scientists had long assumed this process relied on a single biological pathway. In recent years, a second pathway called the futile creatine cycle was identified, but its activation mechanism remained unknown. The McGill team found that glycerol, a molecule released during fat breakdown in cold conditions, binds to an enzyme called TNAP in a specific region dubbed the glycerol pocket, switching on this alternative heat-producing system.

The key insight is that TNAP is not exclusive to fat tissue. It is also essential for bone mineralization, the process that hardens and strengthens bones. Mutations that impair TNAP activity cause hypophosphatasia, a rare inherited condition sometimes called soft bones, which leads to fractures, chronic pain, and skeletal deformities. The same molecular switch active in brown fat also influences bone-forming cells, connecting metabolism and skeletal health in a previously unrecognized way.

For health-conscious individuals, this research highlights how cold exposure and fat metabolism are more intricately linked to bone health than previously understood. It raises the possibility that targeting the TNAP pathway pharmacologically could simultaneously benefit metabolic and skeletal outcomes, potentially relevant to aging populations where both obesity and bone loss are major concerns.

Important caveats apply. The study was conducted in mice and laboratory cell experiments, meaning human applicability is not yet established. Clinical translation will require extensive additional research. Nonetheless, the publication in Nature and the involvement of established researchers lend the findings strong credibility.

Key Findings

  • Glycerol activates TNAP enzyme in brown fat, triggering a secondary calorie-burning heat pathway for the first time explained.
  • The same TNAP switch that drives fat burning also directly influences bone mineralization and hardening cells.
  • TNAP mutations cause hypophosphatasia, a rare soft-bone disorder, linking energy metabolism to skeletal disease.
  • Cold exposure drives glycerol release, connecting cold thermogenesis to both metabolic and bone health pathways.
  • Findings published in Nature suggest potential for dual-target therapies addressing obesity and bone disease simultaneously.

Methodology

This is a news report summarizing a peer-reviewed study published in Nature, conducted by researchers at McGill University. Evidence is based on mouse models and laboratory cell experiments, representing preclinical data. The source institution and journal are highly credible, though the article does not detail sample sizes or specific experimental controls.

Study Limitations

The study was conducted in mice and cell cultures, so human relevance has not been established. Key details such as sample size, experimental controls, and effect magnitude are absent from the news summary. Readers should consult the primary Nature publication for full methodology and data before drawing clinical conclusions.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.